The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: A multicenter, randomized, parallel-controlled, phase II clinical trial.
 
Wencheng Zhang
No Relationships to Disclose
 
Ke Zhang
No Relationships to Disclose
 
Qifeng Wang
No Relationships to Disclose
 
Jianzhong Cao
No Relationships to Disclose
 
Chengcheng Fan
No Relationships to Disclose
 
Wenbin Shen
No Relationships to Disclose
 
Qin Xiao
No Relationships to Disclose
 
Xiaolin Ge
No Relationships to Disclose
 
Xiao Liu
No Relationships to Disclose
 
Tian Zhang
No Relationships to Disclose
 
Xi Chen
No Relationships to Disclose
 
Jie Dong
No Relationships to Disclose
 
Zewei Li
No Relationships to Disclose
 
Zhunhao Zheng
No Relationships to Disclose
 
Cihui Yan
No Relationships to Disclose
 
Qingsong Pang
No Relationships to Disclose
 
Ping Wang
No Relationships to Disclose